hyaluronoglucosaminidase has been researched along with warfarin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenstein, R; Zacharski, LR | 1 |
| Kakegawa, H; Matsumoto, H; Satoh, T | 1 |
| Ladinskaia, MIu; Rudakova, IS | 1 |
| MENTASTI, P; SALVI, F | 1 |
| SALVI, F | 1 |
| ZAWODSKY, L | 1 |
| Era, B; Fais, A; Floris, S; Gatto, G; Kumar, A; Matos, MJ; Pintus, F; Uriarte, E | 1 |
7 other study(ies) available for hyaluronoglucosaminidase and warfarin
| Article | Year |
|---|---|
Reduction of salivary tissue factor (thromboplastin) activity by warfarin therapy.
Topics: Factor VII; Factor VII Deficiency; Factor X; Factor XI Deficiency; Factor XII Deficiency; Freezing; Hemophilia A; Hemophilia B; Humans; Hyaluronoglucosaminidase; Prothrombin; Thromboplastin; Warfarin | 1979 |
Inhibitory effects of hydrangenol derivatives on the activation of hyaluronidase and their antiallergic activities.
Topics: Animals; Benzopyrans; Coumarins; Histamine Release; Hyaluronoglucosaminidase; In Vitro Techniques; Isocoumarins; Mast Cells; Passive Cutaneous Anaphylaxis; Rats; Structure-Activity Relationship | 1988 |
[The mechanism of action of certain esculetin derivatives].
Topics: Animals; Blood Coagulation; Blood Pressure; Coumarins; Enzymes; Histamine H1 Antagonists; Hyaluronoglucosaminidase; Rabbits | 1965 |
[Hyaluronidase-like effect of marcumar in vivo].
Topics: Coumarins; Hyaluronoglucosaminidase; Phenprocoumon | 1956 |
[Inhibiting effect of heparin on hyaluronidase-like effect of marcumar].
Topics: Coumarins; Heparin; Humans; Hyaluronoglucosaminidase; Phenprocoumon | 1956 |
[CONTRIBUTION TO THE MANAGEMENT OF VENOUS THROMBOSES AND THROMBOPHLEBITIS].
Topics: Anticoagulants; Coumarins; Drug Therapy; Female; Fibrinolysis; Heparin; Heparinoids; Humans; Hyaluronoglucosaminidase; Ointments; Postoperative Complications; Puerperal Disorders; Thrombophlebitis; Venous Thrombosis | 1964 |
Hydroxy-3-Phenylcoumarins as Multitarget Compounds for Skin Aging Diseases: Synthesis, Molecular Docking and Tyrosinase, Elastase, Collagenase and Hyaluronidase Inhibition, and Sun Protection Factor.
Topics: Aging; Collagenases; Coumarins; Enzyme Inhibitors; Humans; Hyaluronoglucosaminidase; Molecular Docking Simulation; Monophenol Monooxygenase; Pancreatic Elastase; Skin Aging; Skin Diseases; Sun Protection Factor | 2022 |